Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-25

FDA Approved: POSACONAZOLE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved the original application for posaconazole (generic) by Par Health USA, LLC, marking the availability of a generic posaconazole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)